Algert Global LLC Annexon, Inc. Transaction History

Algert Global LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.63 - $4.63 $22,461 - $63,801	-13,780 Reduced 33.08%	27,880 $127,000
Q3 2023 Nov 13, 2023	BUY	$2.13 - $3.84 $6,390 - $11,520	3,000 Added 7.76%	41,660 $98,000
Q2 2023 Aug 14, 2023	BUY	$2.1 - $6.37 $9,135 - $27,709	4,350 Added 12.68%	38,660 $136,000
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $128,319 - $255,952	34,310 New	34,310 $132,000

156

101M

3.73M

1.3M

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $335M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

Stay updated on Algert Global LLC with notifications on news.